NO20054459L - Liposompreparat for reduksjon av liposomindusert komplementaktivering - Google Patents

Liposompreparat for reduksjon av liposomindusert komplementaktivering

Info

Publication number
NO20054459L
NO20054459L NO20054459A NO20054459A NO20054459L NO 20054459 L NO20054459 L NO 20054459L NO 20054459 A NO20054459 A NO 20054459A NO 20054459 A NO20054459 A NO 20054459A NO 20054459 L NO20054459 L NO 20054459L
Authority
NO
Norway
Prior art keywords
liposome
complement activation
reduction
induced complement
preparation
Prior art date
Application number
NO20054459A
Other languages
English (en)
Norwegian (no)
Inventor
Yechezkel Barenholz
Samuel Zalipsky
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of NO20054459L publication Critical patent/NO20054459L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20054459A 2003-02-28 2005-09-26 Liposompreparat for reduksjon av liposomindusert komplementaktivering NO20054459L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45136203P 2003-02-28 2003-02-28
US52417603P 2003-11-21 2003-11-21
PCT/US2004/006039 WO2004078121A2 (en) 2003-02-28 2004-02-26 Liposome composition for reduction of liposome-induced complement activation

Publications (1)

Publication Number Publication Date
NO20054459L true NO20054459L (no) 2005-09-26

Family

ID=32965548

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054459A NO20054459L (no) 2003-02-28 2005-09-26 Liposompreparat for reduksjon av liposomindusert komplementaktivering

Country Status (11)

Country Link
US (1) US20040213835A1 (ko)
EP (1) EP1596829A2 (ko)
JP (1) JP2006519262A (ko)
KR (1) KR20050115251A (ko)
AU (1) AU2004218489A1 (ko)
BR (1) BRPI0407660A (ko)
CA (1) CA2517352A1 (ko)
MX (1) MXPA05009137A (ko)
NO (1) NO20054459L (ko)
RU (1) RU2005130172A (ko)
WO (1) WO2004078121A2 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9326953B2 (en) 2003-04-25 2016-05-03 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803397B2 (en) * 2003-09-15 2010-09-28 Protiva Biotherapeutics, Inc. Polyethyleneglycol-modified lipid compounds and uses thereof
US20070298094A1 (en) 2004-11-18 2007-12-27 Terumo Kabushiki Kaisha Medicinal Composition, Preparation and Combined Preparation
MX2009005780A (es) * 2006-11-30 2009-06-10 Nektar Therapeutics Al Corp Metodo para preparar un conjugado de polimeros.
EP2119738B1 (en) * 2007-02-05 2014-04-16 Nippon Shinyaku Co., Ltd. Polyethylene glycol derivative
JP2009096730A (ja) * 2007-10-15 2009-05-07 Terumo Corp ヘモグロビン含有リポソーム懸濁液及びその製法
EP2300514B1 (en) * 2008-07-14 2016-03-23 Biocon Limited A method of synthesizing a substantially monodispersed mixture of oligomers
AU2015215843B2 (en) * 2009-02-04 2017-03-09 The Brigham And Women's Hospital, Inc. Nanoscale platinum compounds and methods of use thereof
EP2393854B1 (en) 2009-02-04 2019-12-04 The Brigham and Women's Hospital, Inc. Nanoscale platinum compounds and methods of use thereof
US20100266642A1 (en) * 2009-02-20 2010-10-21 Bind Biosciences, Inc. Modified cells for targeted cell trafficking and uses thereof
JP5949036B2 (ja) * 2011-03-29 2016-07-06 日油株式会社 ポリオキシアルキレン修飾脂質およびその製造方法
ITMI20111866A1 (it) * 2011-10-13 2013-04-14 Bio Ker S R L Polietilenglicoli modificati e loro complessi supramolecolari con macromolecole biologicamente attive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0642021B1 (en) * 1993-09-07 2000-11-02 Wako Pure Chemical Industries Ltd Process for measuring complement activity and reagent used therefor
US5786387A (en) * 1994-03-23 1998-07-28 Meiji Seika Kabushiki Kaisha Lipid double-chain derivative containing polyoxyethylene
DK0929293T3 (da) * 1996-08-23 2004-02-02 Sequus Pharm Inc Liposomer indeholdende en cisplatinforbindelse
TW520297B (en) * 1996-10-11 2003-02-11 Sequus Pharm Inc Fusogenic liposome composition and method
ATE317869T1 (de) * 1999-07-14 2006-03-15 Alza Corp Neutrales lipopolymer und liposomale zusammensetzungen daraus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9326953B2 (en) 2003-04-25 2016-05-03 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds

Also Published As

Publication number Publication date
RU2005130172A (ru) 2006-03-20
WO2004078121A2 (en) 2004-09-16
US20040213835A1 (en) 2004-10-28
EP1596829A2 (en) 2005-11-23
KR20050115251A (ko) 2005-12-07
JP2006519262A (ja) 2006-08-24
AU2004218489A1 (en) 2004-09-16
MXPA05009137A (es) 2005-10-20
CA2517352A1 (en) 2004-09-16
BRPI0407660A (pt) 2006-03-01
WO2004078121A3 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
NO20054459L (no) Liposompreparat for reduksjon av liposomindusert komplementaktivering
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
WO2005096990A3 (en) Novel modification of medical prostheses
WO2004072031A8 (en) Phenylacetamides and their use as glucokinase modulators
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
HK1098960A1 (en) Method and composition for treating rhinitis
EP1698329A4 (en) PHARMACEUTICAL NANOTEILS, METHOD FOR THE PRODUCTION THEREOF AND PARENTERALLY APPLIED PRODUCT FROM NANOTEILES
WO2005027993A3 (en) Vascular access preservation in hemodialysis patients
ZA200707833B (en) Quinone derivative 2,3-dimethoxy-5-methyl-6-(-10-hydroxydecyl)-1,4-benzoquinone for the treatment of muscular dystrophies
WO2005107753A3 (en) Naltrexone long acting formulations and methods of use
WO2003009857A8 (en) Treatment of muscular dystrophy with cord blood cells
IL143824A0 (en) New dialysis method
EP1643999B8 (en) Pyridoxamine for use in the treatment of diabetic nephropathy in type ii diabetes
WO2000008007A3 (de) Cyclopentabenzofuran-derivate und ihre verwendung
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
WO2007033110A3 (en) Liposomes for treatment of multiple myeloma
WO2005065429A3 (en) Composition and method for treatment of hepatic encephalopathy
CA2396209A1 (en) The use of mirtazapine for the treatment of sleep disorders
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
WO2005063757A3 (en) Novel crystalline forms of temozolomide
WO2001007038A3 (en) Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
WO2005034929A3 (en) Tissue remodeling and vascularization
MXPA03006742A (es) Uso de buprenorfina para la terapia de la incontinencia urinaria.
AU2003294952A1 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
IL162391A0 (en) Method of treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application